Wolverine Trading
IBIO icon

Wolverine Trading’s iBio IBIO Stock Holding History

Wolverine Trading’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,930
Closed -$17K – 4551
2022
Q4 		$17K Buy
+1,930
New +$65.3K ﹤0.01% 3759
2021
Q3 		– Sell
-125
Closed -$94K – 6546
2021
Q2 		$94K Buy
+125
New +$91.2K ﹤0.01% 5436
2021
Q1 		– Sell
-82
Closed -$45K – 6101
2020
Q4 		$45K Buy
+82
New +$66.8K ﹤0.01% 4626

Other funds holding IBIO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wolverine Trading's IBIO Position: Q1 2021 in Review

Wolverine Trading sold out of iBio (IBIO) in Q1 2021, closing a stake of 23 shares — an estimated $13K sold.

Wolverine Trading first reported a position in IBIO in Q4 2020 and held it in 1 quarter. The position peaked at $13K in Q4 2020. 91 funds tracked by Wall St. Rank hold IBIO as of Q1 2021.

  • Wolverine Trading reported no remaining iBio position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 23 iBio shares in Q1 2021, an estimated $13K.
  • Wolverine Trading first reported a position in iBio in Q4 2020 and held it in 1 quarter.
  • Wolverine Trading's iBio position peaked at $13K in Q4 2020.
  • 91 funds tracked by Wall St. Rank held iBio as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.